Projektinformation

Beskrivning

EDAP- Early diagnostics and prognostics of Alzheimer’s disease: approaches in municipality, primary health care, specialized care and industry
(LU:s Thematic Collaboration Initiative 2021– ongoing)

The long-term aim of EDAP is to improve trans- and multidisciplinary knowledge exchange and research focusing on Alzheimer’s disease.

We aim to 1) improve early diagnostics and prognostics of Alzheimer´s disease at all levels of patient management, and 2) facilitate early interventions with a meaningful impact on the disease.

Participating faculties
•Medicine
•Science
•Engineering
•Social Sciences
•School of Economics and Management.

External partners
•Region Skåne
•Lunds kommun
•Alzheimer Sverige
•NADIO (före detta Edu Med)
•BioArctic
•Cell Invent
•Eisai
•Geras Solutions
•Lilly
•Lundbeck
•neotiv
•Roche
•(Biogen was part of the application and the start-up phase)

New additional collaborators: Brain Biomarker Solutions in Gothenburg AB, Fujirebio Europé; C2N Diagnostics (US). 

Populärvetenskaplig beskrivning

The long-term aim of EDAP is to improve trans- and multidisciplinary knowledge exchange and research focusing on Alzheimer’s disease.
AkronymEDAP
StatusPågående
Gällande start-/slutdatum2021/09/01 → …

Samarbetspartner

  • Lunds universitet (huvudsaklig)
  • H. Lundbeck AB (Projektpartner)
  • Roche AB (Projektpartner)
  • Eli Lilly and Company (Projektpartner)
  • Eisai Inc. (Projektpartner)
  • Cell Invent (Projektpartner)
  • Geras Solutions AB (Projektpartner)
  • BioArctic AB (Projektpartner)
  • Edu Med AB (Projektpartner)
  • neotiv (Projektpartner)
  • Alzheimer Sweden (Projektpartner)
  • Lunds kommun (Projektpartner)
  • Region Skåne - Primärvården, Malmö (Projektpartner)
  • Region Skåne (Projektpartner)
  • NADIO (former Edu Med AB) (Projektpartner)

Ämnesklassifikation (UKÄ)

  • Neurologi
  • Neurovetenskaper

Nyckelord

  • CASE - Centre for Ageing and Supportive Environments